A detailed history of Exane Derivatives transactions in Sensient Technologies Corp stock. As of the latest transaction made, Exane Derivatives holds 1,539 shares of SXT stock, worth $116,240. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,539
Previous 8,212 81.26%
Holding current value
$116,240
Previous $689,000 82.15%
% of portfolio
0.08%
Previous 0.21%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$73.03 - $87.7 $487,329 - $585,222
-6,673 Reduced 81.26%
1,539 $123,000
Q1 2022

Apr 22, 2022

BUY
$75.1 - $99.43 $516,612 - $683,978
6,879 Added 516.05%
8,212 $689,000
Q4 2021

Jan 28, 2022

BUY
$88.75 - $105.34 $33,458 - $39,713
377 Added 39.44%
1,333 $133,000
Q3 2021

Oct 26, 2021

BUY
$79.47 - $93.3 $75,973 - $89,194
956 New
956 $87,000
Q1 2021

Apr 30, 2021

SELL
$70.53 - $81.02 $967,460 - $1.11 Million
-13,717 Closed
0 $0
Q4 2020

Jan 27, 2021

SELL
$58.47 - $74.98 $81,624 - $104,672
-1,396 Reduced 9.24%
13,717 $1.01 Million
Q3 2020

Oct 06, 2020

BUY
$51.12 - $59.39 $772,576 - $897,561
15,113 New
15,113 $872,000

Others Institutions Holding SXT

About SENSIENT TECHNOLOGIES CORP


  • Ticker SXT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 42,037,900
  • Market Cap $3.18B
  • Description
  • Sensient Technologies Corporation, together with its subsidiaries, develops, manufactures, and markets colors, flavors, and other specialty ingredients in North America, Europe, the Asia Pacific, and internationally. It operates through three segments: Flavors & Extracts Group, Color Group, and Asia Pacific Group. The company offers flavor-d...
More about SXT
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.